Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

Elucidation of the Inhibitory Effect of Phytochemicals with Kir6.2 Wild-Type and Mutant Models Associated in Type-1 Diabetes through Molecular Docking Approach

  • Jagadeb, Manaswini (BIF Centre, Department of Bioinformatics, Orissa University of Agriculture and Technology) ;
  • Konkimalla, V. Badireenath (School of Biological Sciences, National Institute of Science Education and Research) ;
  • Rath, Surya Narayan (BIF Centre, Department of Bioinformatics, Orissa University of Agriculture and Technology) ;
  • Das, Rohit Pritam (BIF Centre, Department of Bioinformatics, Orissa University of Agriculture and Technology)
  • Received : 2014.10.13
  • Accepted : 2014.11.15
  • Published : 2014.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Among all serious diseases globally, diabetes (type 1 and type 2) still poses a major challenge to the world population. Several target proteins have been identified, and the etiology causing diabetes has been reasonably well studied. But, there is still a gap in deciding on the choice of a drug, especially when the target is mutated. Mutations in the KCNJ11 gene, encoding the kir6.2 channel, are reported to be associated with congenital hyperinsulinism, having a major impact in causing type 1 diabetes, and due to the lack of its 3D structure, an attempt has been made to predict the structure of kir6.2, applying fold recognition methods. The current work is intended to investigate the affinity of four phytochemicals namely, curcumin (Curcuma longa), genistein (Genista tinctoria), piperine (Piper nigrum), and pterostilbene (Vitis vinifera) in a normal as well as in a mutant kir6.2 model by adopting a molecular docking methodology. The phytochemicals were docked in both wild and mutated kir6.2 models in two rounds: blind docking followed by ATP-binding pocket-specific docking. From the binding pockets, the common interacting amino acid residues participating strongly within the binding pocket were identified and compared. From the study, we conclude that these phytochemicals have strong affinity in both the normal and mutant kir6.2 model. This work would be helpful for further study of the phytochemicals above for the treatment of type 1 diabetes by targeting the kir6.2 channel.

Keywords

References

  1. Notkins AL. Immunologic and genetic factors in type 1 diabetes. J Biol Chem 2002;277:43545-43548. https://doi.org/10.1074/jbc.R200012200
  2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  3. Gupta R, Bajpai KG, Johri S, Saxena AM. An overview of Indian novel traditional medicinal plants with anti-diabetic potentials. Afr J Tradit Complement Altern Med 2007;5:1-17.
  4. Kuhad A, Chopra K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur J Pharmacol 2007;576:34-42. https://doi.org/10.1016/j.ejphar.2007.08.001
  5. Choi MS, Jung UJ, Yeo J, Kim MJ, Lee MK. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 2008;24:74-81. https://doi.org/10.1002/dmrr.780
  6. Coman C, Rugina OD, Socaciu C. Plants and natural compounds with antidiabetic action. Not Bot Horti Agrobot Cluj Napoca 2012;40:314-325.
  7. McCormack D, McFadden D. A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev 2013;2013:575482.
  8. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838-1849. https://doi.org/10.1056/NEJMoa032922
  9. Karges B, Meissner T, Icks A, Kapellen T, Holl RW. Management of diabetes mellitus in infants. Nat Rev Endocrinol 2012;8:201-211. https://doi.org/10.1038/nrendo.2011.204
  10. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006;49:1190-1197. https://doi.org/10.1007/s00125-006-0246-z
  11. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005;54:2503-2513. https://doi.org/10.2337/diabetes.54.9.2503
  12. Trapp S, Haider S, Jones P, Sansom MS, Ashcroft FM. Identification of residues contributing to the ATP binding site of Kir6.2. EMBO J 2003;22:2903-2912. https://doi.org/10.1093/emboj/cdg282
  13. Kelley LA, Sternberg MJ. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 2009;4:363-371. https://doi.org/10.1038/nprot.2009.2
  14. Xu D, Zhang Y. Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 2011;101:2525-2534. https://doi.org/10.1016/j.bpj.2011.10.024
  15. Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:W407-W410. https://doi.org/10.1093/nar/gkm290

Cited by

  1. Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking vol.14, pp.3, 2016, https://doi.org/10.5808/GI.2016.14.3.96
  2. Study vol.14, pp.4, 2016, https://doi.org/10.5808/GI.2016.14.4.241
  3. (Grape) and its Bioactive Constituents: An Update vol.30, pp.9, 2016, https://doi.org/10.1002/ptr.5644